Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E33.81 EPS (ttm)3.57 Insider Own0.70% Shs Outstand1.78B Perf Week2.80%
Market Cap210.11B Forward P/E26.03 EPS next Y4.64 Insider Trans-3.13% Shs Float1.76B Perf Month8.99%
Income6.40B PEG2.70 EPS next Q0.93 Inst Own75.80% Short Float0.77% Perf Quarter-2.04%
Sales40.23B P/S5.22 EPS this Y24.50% Inst Trans0.11% Short Ratio2.17 Perf Half Y7.05%
Book/sh18.89 P/B6.39 EPS next Y5.00% ROA6.30% Target Price125.95 Perf Year19.82%
Cash/sh4.81 P/C25.10 EPS next 5Y12.53% ROE14.00% 52W Range98.36 - 128.54 Perf YTD10.33%
Dividend1.80 P/FCF66.41 EPS past 5Y7.80% ROI9.70% 52W High-6.02% Beta0.65
Dividend %1.49% Quick Ratio1.30 Sales past 5Y11.10% Gross Margin55.80% 52W Low22.81% ATR1.92
Employees109000 Current Ratio1.80 Sales Q/Q35.30% Oper. Margin13.60% RSI (14)64.72 Volatility1.89% 1.57%
OptionableYes Debt/Eq0.55 EPS Q/Q227.60% Profit Margin11.20% Rel Volume0.76 Prev Close118.25
ShortableYes LT Debt/Eq0.52 EarningsJul 22 BMO Payout56.80% Avg Volume6.24M Price120.80
Recom1.80 SMA202.82% SMA505.30% SMA2005.13% Volume4,717,690 Change2.16%
May-25-21Initiated Barclays Overweight $150
Apr-15-21Initiated Atlantic Equities Neutral $122
Jan-28-21Upgrade BTIG Research Neutral → Buy $140
Sep-11-20Initiated Wolfe Research Outperform $124
Jun-01-20Downgrade Goldman Neutral → Sell $84
Mar-05-20Initiated Citigroup Buy $96
Feb-13-20Initiated Goldman Neutral $96
Feb-06-20Resumed BTIG Research Neutral
Jan-02-20Downgrade Guggenheim Buy → Neutral
Jun-13-19Reiterated BofA/Merrill Buy $81 → $90
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-23-21 01:11PM  
11:42AM  
Jul-22-21 04:05PM  
01:00PM  
11:04AM  
09:21AM  
08:35AM  
07:39AM  
07:37AM  
07:25AM  
07:24AM  
07:15AM  
02:36AM  
Jul-20-21 06:13PM  
Jul-16-21 08:41AM  
Jul-15-21 03:01PM  
09:16AM  
Jul-14-21 05:50PM  
12:57PM  
06:40AM  
Jul-13-21 07:20AM  
Jul-12-21 11:40AM  
Jul-09-21 04:02PM  
02:21PM  
Jul-07-21 05:50PM  
08:55AM  
Jul-06-21 04:47PM  
03:16PM  
08:22AM  
Jul-04-21 03:07AM  
Jul-02-21 01:40PM  
Jun-30-21 05:50PM  
11:31AM  
11:06AM  
09:00AM  
06:00AM  
Jun-25-21 11:30AM  
09:00AM  
08:47AM  
07:41AM  
06:10AM  
Jun-24-21 05:50PM  
04:48PM  
11:40AM  
09:00AM  
Jun-23-21 08:11AM  
Jun-22-21 10:09AM  
07:00AM  
Jun-21-21 09:54AM  
09:47AM  
06:38AM  
Jun-18-21 05:45PM  
02:36PM  
07:42AM  
Jun-17-21 04:30PM  
Jun-15-21 06:19AM  
Jun-14-21 05:50PM  
02:06PM  
08:00AM  
Jun-13-21 05:18AM  
Jun-12-21 07:01AM  
Jun-11-21 11:19AM  
Jun-09-21 06:10AM  
Jun-08-21 07:11AM  
Jun-07-21 05:45PM  
07:46AM  
Jun-04-21 08:45PM  
01:15AM  
Jun-03-21 08:23AM  
07:44AM  
07:00AM  
06:00AM  
Jun-02-21 05:50PM  
02:01PM  
01:54PM  
09:49AM  
05:59AM  
05:00AM  
03:25AM  
02:19AM  
Jun-01-21 07:56PM  
04:43PM  
04:01PM  
12:10PM  
11:41AM  
10:59AM  
08:58AM  
08:37AM  
08:15AM  
08:00AM  
04:24AM  
May-28-21 09:00AM  
May-27-21 05:45PM  
03:45PM  
May-26-21 09:25AM  
May-23-21 05:52AM  
May-21-21 05:45PM  
07:52AM  
06:17AM  
May-20-21 11:30AM  
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Meniere's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watkin JaredSENIOR VICE PRESIDENTApr 30Option Exercise56.8385,0434,832,629144,826May 04 07:07 PM
Watkin JaredSENIOR VICE PRESIDENTApr 30Sale119.9094,57611,339,73959,783May 04 07:07 PM
Karam SammySENIOR VICE PRESIDENTApr 27Option Exercise75.908,600652,74031,526Apr 29 06:42 PM
Karam SammySENIOR VICE PRESIDENTApr 27Sale122.008,6001,049,20022,926Apr 29 06:42 PM
BIRD ROGERSENIOR VICE PRESIDENTApr 27Sale122.009,4391,151,55851,083Apr 29 06:38 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMar 03Sale121.796,200755,09851,550Mar 05 07:11 PM
Ginascol John FEXECUTIVE VICE PRESIDENTMar 01Sale120.6135242,45599,321Mar 02 07:30 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMar 01Sale120.61943113,73582,375Mar 02 07:16 PM
DALE MICHAEL DSENIOR VICE PRESIDENTMar 01Sale120.611,475177,90039,691Mar 02 07:13 PM
BRYNELSEN CHARLESSENIOR VICE PRESIDENTMar 01Sale120.611,002120,85143,550Mar 02 07:02 PM
BIRD ROGERSENIOR VICE PRESIDENTMar 01Sale120.611,113134,23960,522Mar 02 06:55 PM
Ahlberg Gregory ASENIOR VICE PRESIDENTMar 01Sale120.611,052126,88214,045Mar 02 06:49 PM
WOODGRIFT RANDEL WILLIAMSENIOR VICE PRESIDENTMar 01Sale120.611,034124,71150,461Mar 02 08:11 PM
Watkin JaredSENIOR VICE PRESIDENTMar 01Sale120.611,391167,76969,316Mar 02 08:01 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMar 01Sale120.6158770,79857,750Mar 02 07:59 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTMar 01Sale120.611,664200,695107,430Mar 02 07:54 PM
Kumbier MichelleDirectorFeb 23Buy122.502,040249,9007,296Feb 25 06:05 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTFeb 22Sale121.8340048,73475,706Feb 23 07:05 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTFeb 16Sale128.4950564,88763,373Feb 18 05:57 PM
Funck Robert EEXECUTIVE VICE PRESIDENTFeb 02Option Exercise39.1231,3251,225,434193,542Feb 04 06:56 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 02Sale123.033,130385,08459,681Feb 03 07:20 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTFeb 01Option Exercise38.78203,3937,887,902355,289Feb 03 07:10 PM
Scoggins Christopher JSENIOR VICE PRESIDENTFeb 01Option Exercise44.8345,0002,017,20084,706Feb 03 07:14 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 01Option Exercise38.4018,750720,00081,561Feb 03 07:20 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 01Sale122.7918,7502,302,26462,811Feb 03 07:20 PM
Scoggins Christopher JSENIOR VICE PRESIDENTFeb 01Sale123.2445,0005,545,80039,706Feb 03 07:14 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTFeb 01Sale123.47203,39325,113,252151,896Feb 03 07:10 PM
NOVAKOVIC PHEBE NDirectorDec 04Option Exercise34.9714,681513,43145,794Dec 08 05:58 PM
NOVAKOVIC PHEBE NDirectorDec 04Sale107.284,790513,84941,004Dec 08 05:58 PM
OSBORN WILLIAM ADirectorNov 24Option Exercise43.6421,448935,99179,745Nov 25 05:41 PM
Funck Robert EExecutive Vice President & CFOOct 26Option Exercise38.4083,3333,199,987265,550Oct 28 06:33 PM
Funck Robert EExecutive Vice President & CFOOct 26Sale108.8383,3339,068,955182,217Oct 28 06:33 PM
Wainer Andrea FExecutive Vice PresidentSep 30Option Exercise38.4030,0001,152,00074,080Oct 01 05:50 PM
Wainer Andrea FExecutive Vice PresidentSep 30Sale107.0130,0003,210,36044,080Oct 01 05:50 PM
Wainer Andrea FExecutive Vice PresidentSep 23Sale102.473,650374,03144,080Sep 25 05:06 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentSep 11Sale105.282,500263,20046,267Sep 15 06:14 PM
Ginascol John FExecutive Vice PresidentSep 01Option Exercise43.1672,0983,111,584136,775Sep 03 06:33 PM
BIRD ROGERSenior Vice PresidentSep 01Sale108.736,290683,92956,630Sep 03 05:52 PM
CAPEK JOHN MExecutive Vice PresidentAug 27Option Exercise27.0352,3001,413,857369,100Aug 31 06:27 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentAug 27Option Exercise47.0042,4791,996,513144,912Aug 31 06:28 PM
CAPEK JOHN MExecutive Vice PresidentAug 27Sale111.8652,3005,850,278316,800Aug 31 06:27 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentAug 27Sale111.8642,4794,751,701102,433Aug 31 06:28 PM